Endometrial Cancer Lymphadenectomy Trial

The primary aim of this trial is to ascertain whether or not systematic pelvic and para-aortic lymphadenectomy (LNE) does have a significant impact on overall survival (OS) in patients with endometrial cancer (EC) FIGO Stages I or II and high risk of recurrence. Secondary aims will be to evaluate the effect of LNE on disease free survival (DFS) and quality of life, as well as the complications and side effects of LNE and the number of resected lymphnodes. 640 patients with histologically confirmed EC with high risk of recurrence (stage pT1b - pT2, all histological subtypes; pT1a, G3 endometrio

Trial Details

NCT ID
NCT03438474
Phase
NA
Sponsor
Philipps University Marburg
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • Standard surgical procedure for endometrial cancer
  • systematic lymphadenectomy (LNE)
Locations (sample)
  • Aalen, Germany|48.83777,10.0933
  • Amberg, Germany|49.44287,11.86267
  • Ansbach, Germany|49.30481,10.5931
  • Augsburg, Germany|48.37154,10.89851
  • Bad Homburg, Germany|50.22683,8.61816

Key Eligibility Criteria

  • histologically confirmed EC of clinical stages T1b and T2 (all histological types) and stage T1a G3 type 1 (endometrioid, endometriod with squamous…
  • a) no previous surgery concerning EC (primary surgery) or b) surgery after hysterectomy (e.g. for presumed low risk endometrial cancer) is allowed …
  • absence of bulky lymph nodes
  • performance status ECOG 0-1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →